Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Benjamin L. Bryson, Damian J. Junk, Rocky Cipriano & Mark W. Jackson. (2017) STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence. Cell Cycle 16:4, pages 319-334.
Read now
Read now
Shili Xu & Nouri Neamati. (2013) gp130: a promising drug target for cancer therapy. Expert Opinion on Therapeutic Targets 17:11, pages 1303-1328.
Read now
Read now
Natalie A. Sims & Rachelle W. Johnson. (2012) Leukemia inhibitory factor: A paracrine mediator of bone metabolism. Growth Factors 30:2, pages 76-87.
Read now
Read now
Articles from other publishers (35)
Suryavathi Viswanadhapalli, Kalarickal V. Dileep, Kam Y.J. Zhang, Hareesh B. Nair & Ratna K. Vadlamudi. (2022) Targeting LIF/LIFR signaling in cancer. Genes & Diseases 9:4, pages 973-980.
Crossref
Crossref
Carla M. Felcher, Emilia S. Bogni & Edith C. Kordon. (2022) IL-6 Cytokine Family: A Putative Target for Breast Cancer Prevention and Treatment. International Journal of Molecular Sciences 23:3, pages 1809.
Crossref
Crossref
Megan M. Jorgensen & Pilar de la Puente. (2022) Leukemia Inhibitory Factor: An Important Cytokine in Pathologies and Cancer. Biomolecules 12:2, pages 217.
Crossref
Crossref
Nazanin Vaziri, Laleh Shariati, Ali Zarrabi, Ali Farazmand & Shaghayegh Haghjooy Javanmard. (2021) Cancer-Associated Fibroblasts Regulate the Plasticity of Breast Cancer Stemness through the Production of Leukemia Inhibitory Factor. Life 11:12, pages 1298.
Crossref
Crossref
Joe Christianson, Julia Thom Oxford & Cheryl L. Jorcyk. (2021) Emerging Perspectives on Leukemia Inhibitory Factor and its Receptor in Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Carlos Martínez-Pérez, Jess Leung, Charlene Kay, James Meehan, Mark Gray, J Michael Dixon & Arran K Turnbull. (2021) The Signal Transducer IL6ST (gp130) as a Predictive and Prognostic Biomarker in Breast Cancer. Journal of Personalized Medicine 11:7, pages 618.
Crossref
Crossref
Benjamin L. Bryson, Ilaria Tamagno, Sarah E. Taylor, Neetha Parameswaran, Noah M. Chernosky, Nikhila Balasubramaniam & Mark W. Jackson. (2021) Aberrant Induction of a Mesenchymal/Stem Cell Program Engages Senescence in Normal Mammary Epithelial Cells. Molecular Cancer Research 19:4, pages 651-666.
Crossref
Crossref
Nazanin Vaziri, Laleh Shariati & Shaghayegh Haghjooy Javanmard. (2020) Leukemia inhibitory factor: A main controller of breast cancer. Journal of Biosciences 45:1.
Crossref
Crossref
Ziwei Han, Ruisen Zhan, Shijie Chen, Jia Deng, Jian Shi & Weiguo Wang. (2019) miR‐181b/Oncostatin m axis inhibits prostate cancer bone metastasis via modulating osteoclast differentiation. Journal of Cellular Biochemistry 121:2, pages 1664-1674.
Crossref
Crossref
Jihua Shi, Xue Xu, Jun Du, Haimeng Cui & Qingfeng Luo. (2019) Expression of Oncostatin M in Early Gastric Cancer and Precancerous Lesions. Gastroenterology Research and Practice 2019, pages 1-7.
Crossref
Crossref
Qiu-Xu Teng, Yunali V. Ashar, Pranav Gupta, Eddie Gadee, Ying-Fang Fan, Sandra E. Reznik, John N.D. Wurpel & Zhe-Sheng Chen. (2019) Revisiting mTOR inhibitors as anticancer agents. Drug Discovery Today 24:10, pages 2086-2095.
Crossref
Crossref
Yu Shi, Sean Hunter & Tony Hunter. (2019) Stem Cell Factor LIFted as a Promising Clinical Target for Cancer Therapy. Molecular Cancer Therapeutics 18:8, pages 1337-1340.
Crossref
Crossref
Ken Tawara, Hannah Scott, Jacqueline Emathinger, Alex Ide, Ryan Fox, Daniel Greiner, Dollie LaJoie, Danielle Hedeen, Madhuri Nandakumar, Andrew J. Oler, Ryan Holzer & Cheryl Jorcyk. (2019) Co-Expression of VEGF and IL-6 Family Cytokines is Associated with Decreased Survival in HER2 Negative Breast Cancer Patients: Subtype-Specific IL-6 Family Cytokine-Mediated VEGF Secretion. Translational Oncology 12:2, pages 245-255.
Crossref
Crossref
Ken Tawara, Celeste Bolin, Jordan Koncinsky, Sujatha Kadaba, Hunter Covert, Caleb Sutherland, Laura Bond, Joseph Kronz, Joel R. Garbow & Cheryl L. Jorcyk. (2018) OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung. Breast Cancer Research 20:1.
Crossref
Crossref
Srimoyee Mukherjee & Sumita Sengupta Bandyopadhyay. (2018) Mechanism of prostaglandin E2-induced transcriptional up-regulation of Oncostatin-M by CREB and Sp1. Biochemical Journal 475:2, pages 477-494.
Crossref
Crossref
Sukru Gulluoglu, Mesut Sahin, Emre Can Tuysuz, Cumhur Kaan Yaltirik, Aysegul Kuskucu, Ferda Ozkan, Fikrettin Sahin, Ugur Ture & Omer Faruk Bayrak. (2017) Leukemia Inhibitory Factor Promotes Aggressiveness of Chordoma. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 25:7, pages 1177-1188.
Crossref
Crossref
Lapeire Lore, Hendrix An, Lecoutere Evelyne, Van Bockstal Mieke, Vandesompele Jo, Maynard Dawn, Braems Geert, Van Den Broecke Rudy, Müller Cathérine, Bracke Marc, Cocquyt Véronique, Denys Hannelore & De Wever Olivier. (2017) Secretome analysis of breast cancer-associated adipose tissue to identify paracrine regulators of breast cancer growth. Oncotarget 8:29, pages 47239-47249.
Crossref
Crossref
Sanya-Eduarda Kuzet & Cedric Gaggioli. (2016) Fibroblast activation in cancer: when seed fertilizes soil. Cell and Tissue Research 365:3, pages 607-619.
Crossref
Crossref
Jureeporn Chuerduangphui, Chamsai Pientong, Ponlatham Chaiyarit, Natcha Patarapadungkit, Apinya Chotiyano, Bunkerd Kongyingyoes, Supannee Promthet, Piyawut Swangphon, Weerayut Wongjampa & Tipaya Ekalaksananan. (2016) Effect of human papillomavirus 16 oncoproteins on oncostatin M upregulation in oral squamous cell carcinoma. Medical Oncology 33:8.
Crossref
Crossref
June-Hong Kim, Eun-Hyo Cho & Tae-Won Jeon. (2016) The Effects of Long-term Exercise on the Expression of SPARC and OSM in Colon Cancer-induced Mice. Exercise Science 25:2, pages 76-84.
Crossref
Crossref
Mary Doherty, Jacob Smigiel, Damian Junk & Mark Jackson. (2016) Cancer Stem Cell Plasticity Drives Therapeutic Resistance. Cancers 8:12, pages 8.
Crossref
Crossref
Wittaya Chaiwangyen, Stephanie Ospina-Prieto, Diana M. Morales-Prieto, Francisco Lazaro Pereira de Sousa, Jana Pastuschek, Justine S. Fitzgerald, Ekkehard Schleussner & Udo R. Markert. (2016) Oncostatin M and leukaemia inhibitory factor trigger signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2 pathways but result in heterogeneous cellular responses in trophoblast cells. Reproduction, Fertility and Development 28:5, pages 608.
Crossref
Crossref
Bin Liu, Yi Lu, Jinzhi Li, Yanping Liu, Jian Liu & Weiguo Wang. (2015) Leukemia inhibitory factor promotes tumor growth and metastasis in human osteosarcoma via activating STAT3. APMIS 123:10, pages 837-846.
Crossref
Crossref
Jill I Murray, Nathan R West, Leigh C Murphy & Peter H Watson. (2015) Intratumoural inflammation and endocrine resistance in breast cancer. Endocrine-Related Cancer 22:1, pages R51-R67.
Crossref
Crossref
Luguo Sun, Liyan Sui, Xianling Cong, Kejuan Ma, Xiaobo Ma, Yanxin Huang, Cong Fan, Xueqi Fu & Kewei Ma. (2014) Low incidence of IL6ST (gp130) mutations in exon 6 in lung cancer of a Chinese cohort. Cancer Genetics 207:7-8, pages 291-298.
Crossref
Crossref
Jean Albrengues, Isabelle Bourget, Catherine Pons, Vincent Butet, Paul Hofman, Sophie Tartare-Deckert, Chloe C. Feral, Guerrino Meneguzzi & Cedric Gaggioli. (2014) LIF Mediates Proinvasive Activation of Stromal Fibroblasts in Cancer. Cell Reports 7:5, pages 1664-1678.
Crossref
Crossref
Damian Junk, Benjamin Bryson & Mark Jackson. (2014) HiJAK’d Signaling; the STAT3 Paradox in Senescence and Cancer Progression. Cancers 6:2, pages 741-755.
Crossref
Crossref
Xiaoyan Li, Qifeng Yang, Haiyang Yu, Lihua Wu, Yuhan Zhao, Cen Zhang, Xuetian Yue, Zhen Liu, Hao Wu, Bruce G. Haffty, Zhaohui Feng & Wenwei Hu. (2014) LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway. Oncotarget 5:3, pages 788-801.
Crossref
Crossref
Koji Taniguchi & Michael Karin. (2014) IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Seminars in Immunology 26:1, pages 54-74.
Crossref
Crossref
Carl D. Richards. (2013) The Enigmatic Cytokine Oncostatin M and Roles in Disease. ISRN Inflammation 2013, pages 1-23.
Crossref
Crossref
N. R. West, L. C. Murphy & P. H. Watson. (2012) Oncostatin M suppresses oestrogen receptor- expression and is associated with poor outcome in human breast cancer. Endocrine Related Cancer 19:2, pages 181-195.
Crossref
Crossref
Pernille Hojman, Christine Dethlefsen, Claus Brandt, Jakob Hansen, Line Pedersen & Bente Klarlund Pedersen. (2011) Exercise-induced muscle-derived cytokines inhibit mammary cancer cell growth. American Journal of Physiology-Endocrinology and Metabolism 301:3, pages E504-E510.
Crossref
Crossref
Tasneem Kausar, Rinu Sharma, Md. Raghibul Hasan, Anoop Saraya, Tushar K. Chattopadhyay, Siddartha Datta Gupta & Ranju Ralhan. (2011) Overexpression of a splice variant of oncostatin M receptor beta in human esophageal squamous carcinoma. Cellular Oncology 34:3, pages 177-187.
Crossref
Crossref
Jung Eun Shin, Su Hyung Park & Yeun Kyu Jang. (2010) Epigenetic up-regulation of leukemia inhibitory factor (LIF) gene during the progression to breast cancer. Molecules and Cells 31:2, pages 181-189.
Crossref
Crossref
Carolina Schere Levy, Victoria Slomiansky, Albana Gattelli, Karen Nahmod, Federico Pelisch, Matias Blaustein, Anabella Srebrow, Omar A. Coso & Edith C. Kordon. (2010) Tumor necrosis factor alpha induces LIF expression through ERK1/2 activation in mammary epithelial cells. Journal of Cellular Biochemistry 110:4, pages 857-865.
Crossref
Crossref